论文部分内容阅读
目的 :探讨恶性胸腔积液的病因、病理、发病机制及临床特征。方法 :收集总结我院收治的恶性胸腔积液病人76例 ,对其临床特点及各种检查结果进行分析。结果 :肺癌胸膜转移 5 6例 (中央型 2 4例 ,周围型 3 2例 ) ,占 73 7% ,其余分别为肾癌、胸膜间皮瘤、乳腺癌、肝癌、胰腺癌、食管癌、卵巢癌、白血病、恶性淋巴瘤、结肠癌等。胸水CEA均 >10 μg/L ,胸水 /血清CEA均 >1。结论 :恶性胸腔积液以肺癌胸膜转移为最多见 ,占 73 7% ,胸水 /血清CEA >1常提示为恶性胸液
Objective: To investigate the etiology, pathology, pathogenesis and clinical features of malignant pleural effusion. Methods: A total of 76 patients with malignant pleural effusion admitted in our hospital were collected, and their clinical features and various test results were analyzed. Results: There were 56 cases of pleural metastasis in lung cancer (24 cases of central type and 32 cases of peripheral type), accounting for 73.7%. The others were renal cell carcinoma, pleural mesothelioma, breast cancer, liver cancer, pancreatic cancer, esophageal cancer, ovary Cancer, leukemia, malignant lymphoma, colon cancer and the like. Pleural effusion CEA> 10 μg / L, pleural effusion / serum CEA were> 1. Conclusions: Pleural effusion of malignant pleural effusion is the most common form of pleural metastasis in lung cancer, accounting for 73.7%. Pleural fluid / serum CEA> 1 often indicates malignant pleural effusion